I've been diving into some of the more advanced #singlecell#AI approaches recently, and it's super exciting to see two rapidly evolving fields (#LLMs and single cell seq) intersecting, e.g. scBERT and scGPT (links below).
But giv…https://t.co/MWX6LuTOg5 https://t.co/z3C3ufEHl1
I fully second this recent post from Benchling
Generating more #data and developing more sophisticated #AI models will not ensure your #biotech is a success. They may not be flashy buzzwords, but establishing your #dataengineering framework and #datascien…https://t.co/OUNpLXPUna
This is well balanced and realistic summary of lot of what AI is doing on drug discovery right now and what it could do in the future. Recommended reading! https://t.co/MSUKfnip9o
As an engineer in #AI in #drugdiscovery, you'll never be wrong to complain about the lack of quality data (too noisy! too little!, too unconnected!), but as a field, we must be building AI that can leverage the data we have today.…https://t.co/p6bR5fd1NI https://t.co/sVDTFAGL3D
Familiarity with #AI and especially #multimodal#biomedical#data is quickly becoming necessary for modern disease research, including, but not limited to #drugdiscovery
This is a terrific overview of those daunting topics and the…https://t.co/ykOmKHkpt8 https://t.co/385NT3Kg5V
"an important aspect of this is the #AI systems being able to explain their predictions to humans"
I couldn't agree more! At least in the AI for Bio portion of AI in #drugdiscovery, interpretable AI is a must! https://t.co/yqR0J2GnIJ
While #ai can make #drugdiscovery faster and more efficient, to have the biggest impact, and therefore help patients the most, we need to be willing to rethink our processes and approaches.
I'm happy to be able to share this and other thoughts in the late…https://t.co/m4irU64mh1
Right on time to support my blog post from last week (link below) is news that Genentech is joining the OpenTarget consortium. Great to see!
https://t.co/eSs950OAZa https://t.co/Zy1tvvATiS
In #drugdiscovery we hear a lot about how #AI can, with bigger and better #data, find new drugs. I argue that patients will be better served if we, and our AI, instead focused on what we can do with the data we have today https://t.co/vrNpgWriz7
I'm looking forward to speaking at and attending the AI in Pharma: Discovery conference - they've put together a great lineup of talks!
https://t.co/9qb7zwevCH
#ai#pharma#drugdiscovery https://t.co/OoJmEpvceg
I've been pleased to see the conversation about #ai in #drugdiscovery mature recently, and I appreciate @andrew_radin's spot-on take https://t.co/MmkLlrVIGE
My team at Aria Pharmaceuticals has a highly varied and unique lead #bioinformatician role to help us continue to improve our one-of-a-kind #AI#drugdiscovery platform
I'd love to connect with anyone who wants to learn more! https://t.co/6eXwdB1pnl
A great post from @andrew_radin explaining the new Aria Pharmaceuticals brand and the company-wide development that the new name represents! https://t.co/mNPyguFpp0